BEAM
Price
$20.88
Change
+$2.34 (+12.62%)
Updated
Sep 5 closing price
Capitalization
2.11B
65 days until earnings call
SLDB
Price
$5.50
Change
-$0.06 (-1.08%)
Updated
Sep 5 closing price
Capitalization
428.28M
Interact to see
Advertisement

BEAM vs SLDB

Header iconBEAM vs SLDB Comparison
Open Charts BEAM vs SLDBBanner chart's image
Beam Therapeutics
Price$20.88
Change+$2.34 (+12.62%)
Volume$4.72M
Capitalization2.11B
Solid Biosciences
Price$5.50
Change-$0.06 (-1.08%)
Volume$1.14M
Capitalization428.28M
BEAM vs SLDB Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. SLDB commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and SLDB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BEAM: $20.88 vs. SLDB: $5.50)
Brand notoriety: BEAM and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 176% vs. SLDB: 98%
Market capitalization -- BEAM: $2.11B vs. SLDB: $428.28M
BEAM [@Biotechnology] is valued at $2.11B. SLDB’s [@Biotechnology] market capitalization is $428.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 1 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • SLDB’s TA Score: 1 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than SLDB.

Price Growth

BEAM (@Biotechnology) experienced а +27.63% price change this week, while SLDB (@Biotechnology) price change was +0.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.11B) has a higher market cap than SLDB($428M). SLDB YTD gains are higher at: 37.500 vs. BEAM (-15.806). SLDB has higher annual earnings (EBITDA): -152.11M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. SLDB (268M). SLDB has less debt than BEAM: SLDB (23.1M) vs BEAM (155M). BEAM has higher revenues than SLDB: BEAM (60.3M) vs SLDB (0).
BEAMSLDBBEAM / SLDB
Capitalization2.11B428M493%
EBITDA-414.33M-152.11M272%
Gain YTD-15.80637.500-42%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B268M429%
Total Debt155M23.1M671%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMSLDB
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEMFX36.23N/A
N/A
T. Rowe Price Instl Emerging Mkts Eq
TFFYX82.44N/A
N/A
Touchstone Focused Y
REEAX15.26N/A
N/A
RBC Emerging Markets Equity A
MLPIX119.51N/A
N/A
ProFunds Mid Cap Value Inv
AIBBX15.53N/A
N/A
Aristotle Small Cap Equity I-2

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-1.08%
BEAM - SLDB
49%
Loosely correlated
+12.62%
EDIT - SLDB
46%
Loosely correlated
+9.52%
ALLO - SLDB
44%
Loosely correlated
+3.60%
DSGN - SLDB
44%
Loosely correlated
+5.56%
SYRE - SLDB
44%
Loosely correlated
+0.06%
More